Sage Journals: Discover world-class research

Open access

Review article

First published 2025

Aggressive treatment of early acute focal inflammatory activity to extend the window for BTK inhibition in multiple sclerosis

Joost Smolders, Ide Smets, Beatrijs Wokke

Therapeutic Advances in Neurological Disorders

Retricted access

Research article

First published 2016-06

Btk Inhibitor RN983 Delivered by Dry Powder Nose-only Aerosol Inhalation Inhibits Bronchoconstriction and Pulmonary Inflammation in the Ovalbumin Allergic Mouse Model of Asthma

Jonathan E. Phillips, Lorena Renteria, Lisa Burns [...]

Journal of Aerosol Medicine and Pulmonary Drug Delivery

Open access

Research article

First published 2019-12

Bruton’s Tyrosine Kinase Inhibition Promotes Myelin Repair

Elodie Martin, Marie-Stéphane Aigrot, Roland Grenningloh [...]

Brain Plasticity

Retricted access

Research article

First published 2007-12

A FLIPR-Based Assay to Assess Potency and Selectivity of Inhibitors of the TEC Family Kinases Btk and Itk

John Douhan, Joy S. Miyashiro, Xiaochuan Zhou [...]

ASSAY and Drug Development Technologies

Retricted access

Research article

First published 2007-02

Chemical Genetic Transcriptional Fingerprinting for Selectivity Profiling of Kinase Inhibitors

Shan Jiang, Julie DiPaolo, Kevin Currie [...]

ASSAY and Drug Development Technologies

Open access

Review article

First published 2020

BTK inhibitors and anti-CD20 monoclonal antibodies for treatment-naïve elderly patients with CLL

Andrew Rogers, Jennifer A. Woyach

Therapeutic Advances in Hematology

Open access

Review article

First published 2022

The potential of pirtobrutinib in multiple B-cell malignancies

Jeffrey L. Jensen, Anthony R. Mato, Camila Pena [...]

Therapeutic Advances in Hematology

Open access

Review article

First published 2021

The role of acalabrutinib in adults with chronic lymphocytic leukemia

Bita Fakhri, Charalambos Andreadis

Therapeutic Advances in Hematology

Open access

Research article

First published 2022-11

The Serum- and Glucocorticoid-Inducible Kinase 1 (SGK1) as a Novel Therapeutic Target in Mantle Cell Lymphoma

Jiao Li, Hui Yu, Xing Wang [...]

Cancer Control

Open access

Research article

First published 2023

Rilzabrutinib versus placebo in adults and adolescents with persistent or chronic immune thrombocytopenia: LUNA 3 phase III study

David J. Kuter, James B. Bussel, Waleed Ghanima [...]

Therapeutic Advances in Hematology

Search results